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There are several requirements for the early detection of AMI with biochemical markers: 
The biochemical marker should be: 
! Specific 
! Sensitive 
! Fast elevated after the clinical onset of the symptoms.  
The test should be: 
! Easy to perform 
! Give a fast result 
! Preferably bedside 
! Inexpensive 
Here, we demonstrate the biochemical characteristics of heart-type Fatty Acid-Binding Protein (FABP) 
in AMI and UAP patients. Also, we show some preliminary data on a new in-house made quantitative 





Fig. 1 The layout of the dipstick rapid test 
Methods:  
! Patients: 50 patients of the CCU of PWH are included in the study diagnosed with UAP or 
AMI. Eight blood samples per patient were taken at 0-72 hours after admission and analyzed 
with a laboratory ELISA test. 
! Rapid test procedure: 80 ml plasma or serum is added on the sample pad. Within 5 minutes, 
the strip can be read out with an optical reader (the PART from LRE, Munich, Germany). 
Results: 
A release curve for AMI patients shows a significantly elevated FABP concentration already 1 hour 
after infarction, whereas for CPK, this is found after 3 hours (Fig. 2).  


































 Fig. 2 Comparison of the 
release of FABP (15 kD) and Creatine PhosphoKinase (CPK, 86 kD) 
 
 
Comparing the ROC curve for patients arriving at the hospital and 1 hour later for  FABP and CPK 
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 Fig. 3 Differentiation of AMI and Unstable 
Angina Pectoris (UAP) patients at admission (upper) and one hour after admission (lower) 
The preliminary results of the rapid test show for selected plasma and serum samples a measuring 
range of 0-200 ng/ml FABP (Fig. 4). 
















Fig. 4B Patient Samples analysed with the rapid test 
Conclusion:  
The availability of a rapid bedside test for FABP enables faster diagnosis in patients with no clear 
ECG. This can be used for both inclusion or exclusion of AMI. 
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